Iman El-Hariry

Iman El-Hariry is currently serving as the Chief Medical Officer at ERYTECH Pharma since January 2015. Prior to this role, she held the position of President at Azure Oncology Consulting from July 2014 to July 2015. With extensive experience in the pharmaceutical industry, Iman has also worked at Synta Pharmaceuticals as the VP of Clinical Research and at Astellas Pharma as the Global Head of Oncology. She has a strong background in clinical development, strategic planning, and overseeing clinical trials, particularly in the field of oncology. Iman's educational background includes a PhD in Cancer Research from Imperial College London and an MD in Oncology from Alexandria University.